CORD iPS is a biotechnology company that combines modern medicine, science, and technology in order to make innovative products and services available in Serbia and customized for each client.
We made it possible for clients to invest in the future health of their child in the right and safest way.
Driven by the experience of the largest biomedical centers for the cryopreservation of stem cells Vita 34 and Seracell from Germany, unlocking the power of the whole genome by cooperating with Illumina from USA, and collaborating with Novogenia from Austria, we enable high-tech medical services and products to be widely available in Serbia.
Exclusive agent for:
CORD BLOOD INDUSTRY
Seracell Stammzelltechnologie GmbH, Germany
Vita34 AG, Germany
GENETIC TESTING
Illumina inc., USA
Novogenia, Austria
DNA Plus, Germany
*CORD iPS is the triple-A rated company (AAA - Bisnode)
Company Details
Cord Ips Questions
Cord Ips's website is cord.rs
Cord Ips's LinkedIn profile is https://rs.linkedin.com/company/cord-ips
Cord Ips has
19 employees.
View email and phone details for 19
employees at Cord Ips.
Cord Ips's industry is
Biotechnology Research
Cord Ips's top competitors are
Global Regenerative Academy Inc.,
Segova Biotechnology,
Hemofarm A.d.,
Labena Srbija,
Vincula Biotech Group,
Rmos - Regenerative Medicine Orthopaedic Society,
Bio Save Group,
4u Pharma,
Bebac.com,
Biocell Hospital.
Cord Ips's categories are Biotechnology Research
Cord Ips's founding year is 2010
